Week of December 12 2025 - SSG Insights

CMS Announces 2027 Prices for 15 Drugs, Including Wegovy

The Centers for Medicare and Medicaid Services (CMS) has finalized the latest round of Medicare drug price negotiations, selecting 15 high-cost drugs covered under Medicare Part D for reduced pricing.

IRS Issues Guidance on New Trump Accounts for Children

On Dec. 2, 2025, the IRS issued Notice 2025-68 to announce upcoming regulations and provide initial guidance regarding Trump Accounts. Trump Accounts are a new type of tax-favored savings account for children under the age of 18 that will be available in 2026. This SSG Compliance Advisor summarizes the guidance from Notice 2025-68, including the rules for employer contributions to Trump Accounts.

Federal Initiatives to Align U.S. Drug Prices With Global Rates

Recent federal initiatives and industry agreements may affect prescription drug pricing in the United States. This Compliance Advisor provides an overview of key developments and potential action steps for employers.